Suneel Chilukuri
MOHS-Micrographic Surgery · Bellaire, TXNPI 1578674305
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by AbbVie at 58.0% of the total. Among mohs-micrographic surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 335 payments — averaging $860.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$167K
- Revance Therapeutics, Inc.$73K
- Galderma Laboratories, L.p.$36K
- Aclaris Therapeutics, Inc.$9K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$2K
- Merz North America, Inc.$413
- plus $752 from 7 others
Across 12 payments — averaging $2865.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$34K
What the payments were for
- Consulting fees$110,28638%
- Speaking & faculty fees$135,37247%
- Travel & lodging$30,46211%
- Food & beverage$12,0114%
- Education$280%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 219 | $167,166 |
| Revance Therapeutics, Inc. | 33 | $72,508 |
| Galderma Laboratories, L.p. | 42 | $36,237 |
| Aclaris Therapeutics, Inc. | 15 | $9,488 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $1,596 |
| Merz North America, Inc. | 8 | $413 |
| Sun Pharmaceutical Industries Inc. | 5 | $217 |
| Solta Medical, A Division Of Bausch Health US, LLC | 2 | $165 |
| Endo Pharmaceuticals Inc. | 4 | $143 |
| VYNE Pharmaceuticals Inc. | 1 | $67 |
| E.r. Squibb & Sons, L.L.C. | 1 | $62 |
| Arcutis Biotherapeutics, Inc. | 1 | $58 |
| Incyte Corporation | 1 | $41 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAXXIFY$71,953
- BOTOX COSMETIC$50,847
- BOTOX$30,656
- NATRELLE SALINE-FILLED BREAST IMPLANTS$8,280
- ESKATA$3,947
- ALTRENO$1,500
- XEOMIN$224
- DYSPORT$149
How this compares
$288,158 in reported general payments places this provider in the 95th percentile of 109 mohs-micrographic surgery providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine-PrilocaineLidocaine/Prilocaine | 21 | $215 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Bellaire
- Kayla McNieceBellaire$13K
- Jeffrey BubleyBellaire$4K
- Leonard GoldbergBellaire$4K
- Aaron FarbergRockwall$1.5M
- Ryan O QuinnSan Antonio$167K
- Paul FriedmanHouston$131K
- Brent SpencerFrisco$45K
- Julie CroleyThe Woodlands$30K
- Hubert ChodkiewiczCedar Park$13K
- Meredith OrsethCedar Hill$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.